A Novel Enolase-1 Antibody Targets Multiple Interacting Players in the Tumor Microenvironment of Advanced Prostate Cancer

Prostate cancer is one of the most common causes of cancer death in men worldwide, and the treatment options are limited for patients with advanced stages of prostate cancer. Upon oncogenic or inflammatory stimulation, tumor cells or immune cells express cell surface enolase-1 (ENO1) as plasminogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mao-Lin, Yuan, Ta-Tung, Chuang, Chi-Fen, Huang, Yung-Tsang, Chung, I-Che, Huang, Wei-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Large Molecule Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662882/
https://www.ncbi.nlm.nih.gov/pubmed/35700013
http://dx.doi.org/10.1158/1535-7163.MCT-21-0285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662882/
https://www.ncbi.nlm.nih.gov/pubmed/35700013
http://dx.doi.org/10.1158/1535-7163.MCT-21-0285

Ejemplares similares